EQUATOR-Oncology: reducing the latitude of cancer trial design and reporting

por Majeed, Habeeb, Amir, Eitan
Publicado 2018

The Real-World Experience of the Biosimilar (Grastofil(®)) to the Reference Biologic (Neupogen(®)) in Breast Cancer and Lymphoma: A Canadian Single-Centre Retrospective Study

por Wong, Gina, Wang, Katie, Pasetka, Mark, Zhang, Liying, Lou, Julia, Majeed, Habeeb, Flores, Jerome, Lam, Emily, DeAngelis, Carlo
Publicado 2022

A retrospective review of the real-world experience of the Pegfilgrastim biosimilar (Lapelga®) to the reference biologic (Neulasta®)

por Wong, Gina, Zhang, Liying, Majeed, Habeeb, Razvi, Yasmeen, DeAngelis, Carlo, Lam, Emily, McKenzie, Erin, Wang, Katie, Pasetka, Mark
Publicado 2020

Primary Febrile Neutropenia Prophylaxis for Patients Who Receive FEC-D Chemotherapy for Breast Cancer: A Systematic Review

por Fernandes, Ricardo, Mazzarello, Sasha, Stober, Carol, Ibrahim, Mohamed F.K., Dudani, Shaan, Perdrizet, Kirstin, Majeed, Habeeb, Vandermeer, Lisa, Shorr, Risa, Hutton, Brian, Fergusson, Dean, Gyawali, Bishal, Clemons, Mark
Publicado 2017